Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups-Reference-Cited by-同舟云学术

Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups

Published:2019-05-13 Issue:10 Volume:19 Page:2795-2804
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Mohamed Moataz E.¹²^ORCID,Schladt David P.³,Guan Weihua⁴,Wu Baolin⁴,Setten Jessica⁵,Keating Brendan J.⁶,Iklé David⁷,Remmel Rory P.⁸,Dorr Casey R.³,Mannon Roslyn B.⁹,Matas Arthur J.¹⁰,Israni Ajay K.³¹¹,Oetting William S.¹,Jacobson Pamala A.¹^ORCID,Cecka J. Michael,Connett John,Cosio Fernando G.,Gaston Robert,Gourishankar Sita,Grande Joseph P.,Hunsicker Lawrence,Kasiske Bertram,Rush David,

Affiliation:

1. Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis Minnesota

2. Department of Pharmacy Practice Faculty of Pharmacy Helwan University Cairo Egypt

3. Hennepin Healthcare Research Institute Minneapolis Minnesota

4. Division of Biostatistics School of Public Health University of Minnesota Minneapolis Minnesota

5. Department of Cardiology University Medical Center Utrecht University of Utrecht Utrecht the Netherlands

6. Department of Surgery School of Medicine University of Pennsylvania Philadelphia Pennsylvania

7. Rho Chapel Hill North Carolina

8. Department of Medicinal Chemistry College of Pharmacy University of Minnesota Minneapolis Minnesota

9. Division of Nephrology University of Alabama Birmingham Alabama

10. Department of Surgery University of Minnesota Minneapolis Minnesota

11. Department of Epidemiology & Community Health University of Minnesota Minneapolis Minnesota

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15385

Reference74 articles.

1. Tailoring tacrolimus therapy in kidney transplantation

2. Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation

3. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes

4. Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients

5. Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients;The Pharmacogenomics Journal;2024-08-23

2. Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study;The Journal of Clinical Pharmacology;2024-05-20

3. Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data;The Pharmacogenomics Journal;2024-05-15

4. Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review;Pharmacogenomics;2024-05-02

5. Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio;Nefrología (English Edition);2024-03